Publication | Closed Access
EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models
104
Citations
25
References
1993
Year
Tumor BiologyPreclinical ModelsMedicineBone Marrow ToxicityAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchDrug DiscoveryHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1